Recent Articles

How is PSA used to monitor prostate cancer?

Effects of sleep deprivation

Progressive relaxation techniques for insomnia

How to test for sleep apnea: At home or in a lab

How sleep deprivation can harm your health

Extreme heat endangers older adults: What to know and do

Want to cool down? 14 ideas to try

What is a PSA test and how is it used?

Blood sugar–friendly fruits if you have diabetes

Gratitude enhances health, brings happiness — and may even lengthen lives

For "bad" cholesterol, lower is better; dual drug therapy may help

High cholesterol, in particular high low-density lipoprotein (LDL), the so-called bad cholesterol, is a key cause of heart disease. A large clinical trial called IMPROVE-IT set out in 2005 to answer two key questions about LDL:

How low should drug therapy drive LDL?
Can drugs other than statins, the gold standard for lowering cholesterol, help?

The results of IMPROVE-IT were recently published in The New England Journal of Medicine.

Dr. Deepak L. Bhatt, Editor in Chief of the Harvard Heart Letter, talked about the significance of the IMPROVE-IT findings with Dr. Christopher P. Cannon, the trial's lead investigator, and Dr. John A. Jarcho, an editor of The New England Journal of Medicine.

Print This Page

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.